Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for STOKE THERAPEUTICS INC COMMON STOCK (STOK).
- Disclosed ownership: 14%.
- Date of event: 30 Jun 2025.
FMR LLC - 30 Jun 2025 SCHEDULE 13G/A Report for STOKE THERAPEUTICS INC COMMON STOCK (STOK)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Security
- STOKE THERAPEUTICS INC COMMON STOCK
- Symbol
- STOK
- Shares outstanding
- 54,507,221 shares
- Disclosed Ownership
- 7,412,982 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Aug 2025, 12:14:18 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 06 Jun 2025
- Next filing
- 05 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 14% ownership in STOKE THERAPEUTICS INC COMMON STOCK (STOK) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 06 Jun 2025.
- Current filing was accepted on 06 Aug 2025, 12:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | 7,412,982 | 7,405,833 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 14% | 7,412,982 | 0 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson* |